FAKTOR-OPTIONSSCHEIN - 10X GENOMICS Stock

Certificat

DE000MD5E268

Market Closed - Börse Stuttgart 15:49:23 2024-05-24 EDT
0.172 EUR -1.15% Intraday chart for FAKTOR-OPTIONSSCHEIN - 10X GENOMICS
Current month-55.90%
1 month-47.88%
Date Price Change
24-05-24 0.172 -1.15%
24-05-23 0.174 -14.71%
24-05-22 0.204 -0.49%
24-05-21 0.205 -8.48%
24-05-20 0.224 -3.45%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 03:49 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying 10X GENOMICS, INC.
Issuer Morgan Stanley
WKN MD5E26
ISINDE000MD5E268
Date issued 2022-06-20
Strike 15.3 $
Maturity Unlimited
Parity 39.96 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 26.73
Lowest since issue 0.17
Spread 0.002
Spread %1.18%

Company Profile

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.
Sector
-
More about the company

Ratings for 10x Genomics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Consensus: 10x Genomics, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
22.59 USD
Average target price
41.14 USD
Spread / Average Target
+82.13%
Consensus